Zeliha Emrence
Impact in
-
- Ocular Diseases and Behçet’s Syndrome
Papers in
-
- Inflammasome and immune disorders 3
-
- Acute Myeloid Leukemia Research 3
- Autoimmune and Inflammatory Disorders Research 3
- Co-authors
- Duran Üstek (12 shared papers)Ebru Toksoy Öner (2 shared papers)Neslihan Abacı (10 shared papers)Kazım Yalçın Arğa (3 shared papers)Fulya Coşan (4 shared papers)Muzaffer Arıkan (2 shared papers)Ayşe Çefle (2 shared papers)Esin Aktaş Çetin (1 shared paper)
- Journals
- Lara D. Veeken (2 papers)SpringerPlus (1 paper)Infection Genetics and Evolution (1 paper)Journal of Bacteriology (1 paper)Pediatric Rheumatology (1 paper)
- Partner nations
- TürkiyeUnited StatesAntigua and Barbuda
In The Last Decade
Zeliha Emrence
16 papers receiving 175 citations
Peers
Comparison fields: 5 of 55
- Ophthalmology 26
- Gastroenterology 15
- Hematology 30
- Biotechnology 18
- Rheumatology 24
Countries citing papers authored by Zeliha Emrence
This map shows the geographic impact of Zeliha Emrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeliha Emrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeliha Emrence more than expected).
Fields of papers citing papers by Zeliha Emrence
This network shows the impact of papers produced by Zeliha Emrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeliha Emrence. The network helps show where Zeliha Emrence may publish in the future.
Co-authors
The 25 scholars most cited alongside Zeliha Emrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 36 | |
| 2 | 2017 | 28 | |
| 3 | 2012 | 14 | |
| 4 | Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction. | 2020 | 13 |
| 5 | 2012 | 12 | |
| 6 | Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism? | 2016 | 12 |
| 7 | 2012 | 10 | |
| 8 | Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. | 2016 | 10 |
| 9 | 2022 | 9 | |
| 10 | 2012 | 9 | |
| 11 | 2012 | 9 | |
| 12 | 2012 | 8 | |
| 13 | 2020 | 4 | |
| 14 | 2025 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2023 | 0 | |
| 18 | 2012 | 0 | |
| 19 | 2015 | 0 |
About Zeliha Emrence
Zeliha Emrence is a scholar working on Molecular Biology, Hematology, Rheumatology, Immunology and Surgery, having authored 19 papers that have together received 177 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Ocular Diseases and Behçet’s Syndrome (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Inflammasome and immune disorders (3 papers), Systemic Lupus Erythematosus Research (3 papers), Microbial Metabolites in Food Biotechnology (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Ophthalmology (26 citations), Gastroenterology (15 citations), Hematology (30 citations), Biotechnology (18 citations) and Rheumatology (24 citations). Zeliha Emrence has collaborated with scholars based in Türkiye, United States and Antigua and Barbuda. Frequent co-authors include Duran Üstek, Ebru Toksoy Öner, Neslihan Abacı, Kazım Yalçın Arğa, Fulya Coşan, Muzaffer Arıkan, Ayşe Çefle, Esin Aktaş Çetin, Tuğba Özer and Nilgün Akdeniz. Their work appears in journals such as Lara D. Veeken, SpringerPlus, Infection Genetics and Evolution, Journal of Bacteriology and Pediatric Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.